FDA clears ChoiceSpine’s titanium lumbar fusion devices: 3 takeaways

Knoxville, Tenn.-based ChoiceSpine’s titanium lumbar interbody fusion devices received FDA clearance.

Advertisement

Here are three takeaways:

 

1. ChoiceSpine will provide the titanium interbody devices for transitional posterior lumbar interbody fusion.

 

2. The company also plans to offer titanium interbody devices for tranforaminal lumbar interbody fusion.

 

3. Surgeons may also use the devices for the visualized lateral interbody fusion approach.

 

More articles on devices:
Global knee & hip replacements market to grow at CAGR 5%+ through 2021: 5 key trends
NeuroMetrix hits 20-year anniversary: 5 points
NuVasive institutional sentiment hits 1.19 in Q4 2015 — 5 notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.